Your browser doesn't support javascript.
loading
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Robson, Mark; Im, Seock-Ah; Senkus, Elzbieta; Xu, Binghe; Domchek, Susan M; Masuda, Norikazu; Delaloge, Suzette; Li, Wei; Tung, Nadine; Armstrong, Anne; Wu, Wenting; Goessl, Carsten; Runswick, Sarah; Conte, Pierfranco.
Affiliation
  • Robson M; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Im SA; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Senkus E; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Xu B; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Domchek SM; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Masuda N; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Delaloge S; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Li W; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Tung N; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Armstrong A; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Wu W; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Goessl C; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Runswick S; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
  • Conte P; From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdansk, Gdansk, Poland (E.S.); National Cancer Center-Cancer Hospital, C
N Engl J Med ; 377(6): 523-533, 2017 08 10.
Article in En | MEDLINE | ID: mdl-28578601
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phthalazines / Piperazines / Breast Neoplasms / Germ-Line Mutation / Genes, BRCA1 / Genes, BRCA2 / Poly(ADP-ribose) Polymerase Inhibitors / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: N Engl J Med Year: 2017 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phthalazines / Piperazines / Breast Neoplasms / Germ-Line Mutation / Genes, BRCA1 / Genes, BRCA2 / Poly(ADP-ribose) Polymerase Inhibitors / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: N Engl J Med Year: 2017 Type: Article